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ScienceDirectAfrican trypanosomes cause devastating diseases in humans
and domestic animals. The parasites evolved early in the
eukaryotic lineage and have numerous biochemical
peculiarities that distinguish them from other systems. These
include unconventional mechanisms for expressing nuclear
and mitochondrial genes as well as unusual subcellular
localizations for a variety of enzymes. Systems biology has
arisen partly to allow contextualization of the massive datasets
that describe individual chemical parts of biological systems.
Here we describe recent efforts to collect and analyse data
pertaining to all aspects of the trypanosome’s biochemical
physiology that go some way to describing the parasite as an
integrated system.
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Human African trypanosomiasis
African trypanosomes of the Trypanosoma brucei group
cause human African trypanosomiasis, a disease of sub-
Saharan Africa whose distribution is limited by the eco-
logical range of the tsetse fly vectors that transmit these
parasites [1].
T. brucei gambiense and T. b. rhodesiense cause chronic and
acute forms of the disease, respectively. After a tsetse bite,
trypanosomes enter the blood and lymphatic system. When
non human-infectious African trypanosomes enter the
bloodstream, lipoprotein particles enter through endocyto-
sis after binding a haptoglobin like receptor, then lyse due to
trypanosome lytic factors (TLFs) including ApolipoproteinCurrent Opinion in Microbiology 2014, 20:162–169 L1 [2]. T. b. rhodesiense avoids lysis through its serum
resistance associated (SRA) protein, a mutated version of
a variant surface glycoprotein (VSG), that binds and neutral-
ises ApoL1 [2]. T. b. gambiense express reduced levels of the
haptoglobin-like receptor [3] and also express TgsGP [4,5],
another VSG derivative that protects against lysis by mod-
ifying membrane fluidity. People carrying rare mutations in
ApoL1 become susceptible to other species of trypano-
some, such as Trypanosoma evansi [6,7].
In humans, trypanosomes establish chronic infections by
varying expression of the thousand or so genes that
encode different coat glycoproteins [8]. These shroud
the parasite and exclude immune effectors from the cell
surface. Antibodies against these coat proteins eventually
induce complement mediated lysis of parasites. However,
cells expressing other coat variants escape and proliferate
until new antibodies are generated. Eventually, parasites
invade the central nervous system triggering stage 2
disease, characterized by progressive deterioration of
brain function leading to death. Metacyclic forms injected
by the tsetse fly are non-proliferative and these differen-
tiate into slender bloodstream forms, adapted to live in the
haemolymphatic system and later cerebrospinal fluid
(CSF). A quorum-sensing pathway [9] triggers differen-
tiation of slender forms into a non-proliferative stumpy
form whose biochemistry is pre-adapted for survival in the
tsetse midgut. Here, stumpy forms differentiate into repli-
cative procyclic forms that eventually, after transforming
through several other forms, become the metacyclic forms
pre-adapted biochemically for the mammalian host.
The parasite
Trypanosomes belong to the order Kinetoplastida, named
after the kinetoplast, a dense intercatenated network of
circular mitochondrial DNA molecules (kDNA). The
genetic code of kDNA is perturbed such that genes are
transcribed into RNA molecules that must be edited into
translatable mRNA through the addition or removal of U-
residues [10]. The expression of nuclear genes is also
unconventional (see later).
Other unusual cellular phenomena in trypanosomes in-
clude a sub-pellicular microtubule array that maintains
cell morphology. Various organelles include acidocalci-
somes, involved in ion and pH homeostasis. Peroxisomes
of trypanosomes are highly adapted containing the first
seven enzymes of glycolysis, hence their being named
‘glycosomes’. Redox balance involves two glutathione
molecules complexed to spermidine to create the signa-
ture metabolite, trypanothione (N1,N8-bis(glutathionyl)-
spermidine). Much effort has focused on attempting towww.sciencedirect.com
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become new drugs.
The trypanosome’s nuclear genome and gene
expression
T. brucei is diploid, possessing around 10,000 nuclear,
protein-coding genes across 11 pairs of classical chromo-
somes in the megabase range (0.9–5.7 Mb) [11]. They
also contain variable numbers of intermediate (0.3–
0.9 Mb) and mini chromosomes (0.05–0.1 Mb) as VSG
gene repositories [12]. Other genes are present in single or
multiple copies, often in tandem arrays. Some correlation
exists between gene copy number and transcription level.
Next Generation Sequencing technologies have allowed
comparison between different species [13], subspecies and
strains and efforts are underway to compare trypanosomes
that are, for example, responsible for different pathologies,
host-range specificity and other phenotypic traits.
VSG gene transcription involves an RNA polymerase 1-
containing extranucleolar expression site body (ESB) that
ensures the monoallelic expression of VSGs, since only one
vsg gene can be associated with the ESB at a time [14].
Elsewhere, large parts of the genome are transcribed
constitutively and expression is regulated primarily at
the level of RNA stability and translational control.
The transcription of genes encoding the main surface
proteins of procyclic forms, called procyclins, is also PolI
dependent. Transcription of other protein coding genes is
dependent on polymerase II, although PolII promoters
have not been found.
Different genes give rise to transcripts and proteins of
different abundance throughout the life cycle. For example,
the bloodstream form specific glucose transporter gene,
THT1, is found only in bloodstream form (BSF) and this
is also reflected in steady-state RNA levels [15]. Conversely,
the pentose phosphate pathway enzyme transketolase is
procyclic specific [16]. Several genome-wide transcription
studies have been performed [17–20]. Meta-analysis of this
data identified co-expression networks of genes and some
overlap with similar networks from the related parasite
Leishmania infantum, providing clues on functional assign-
ment by association [19]. Expression analysis also revealed
the mechanistic pathways involved in differentiation, for
example the transcription of a phosphatase encoding gene,
whose expression is pivotal in transformation to stumpy
forms, was markedly upregulated [21]. Carboxylic acid
transporters associated with the stumpy to procyclic trans-
formation [22] were also identified through differentiation-
linked transcription of these genes.
As transcription is constitutive, large polycistronic tran-
scripts must be processed by the combined action of
polyadenylation at the 30 end of individual genes andwww.sciencedirect.com addition of a spliced leader sequence at the 50 end [23]
(Figure 1A).
Regulatory elements within the 30 untranslated region
(30UTR) of transcripts can determine stability of the
message or translation efficiency. RNA-binding proteins
of different classes (RRM, ALBA, CCCH and puf
families) [24] have all been characterized. One member,
RBP10, was shown to be key in controlling bloodstream
form specific gene expression [25] and its phosphorylation
seems to associate with its control function. Another
protein, RBP6, was found to be highly expressed in
parasites within the tsetse fly proventiculus [26].
Expressing RBP6 in procyclics was sufficient to stimulate
their transformation to mammal-infective metacyclics
expressing VSG [26]. RNA binding proteins are pivotal,
therefore, in determining expression of families of genes
in pre-programmed pathways.
Other genes and pathways are under environmental con-
trol. For example, proline is the usual substrate for energy
metabolism in tsetse flies, but procyclic trypanosomes
prefer glucose if available [27]. Threonine’s use in acetate
production is also regulated based on glucose availability
[28].
Polyamine homeostasis is of particular importance. Tight
regulation occurs and the metabolite, decarboxylated S-
adenosylmethionine (dcSAM) plays a central role. S-ade-
nosylmethionine decarboxylase (SAMDC), which con-
verts SAM to dcSAM [29], is activated over 100 fold
when bound to a catalytically dead homologue called
prozyme [30]. Prozyme’s RNA has a region within its
3’UTR that is proposed to bind to dcSAM (Figure 1B).
When that metabolite is abundant, translation of the
message arrests. As dcSAM levels fall, the unbound
message is translated, creating more prozyme. dcSAM
then rises, binds to the mRNA and represses translation
again. Such feedback systems involving metabolite,
protein and message offer exquisite balance of metab-
olism and understanding such regulation is the essence of
modern systems biology. The discovery that a weakly
active deoxyhypusine synthase also associates with an
inactivate paralogue, encoded by a separate gene, to
create a highly active heterodimer [31], points to our
only just beginning to unravel much of the complexity of
the trypanosome system.
Genome-wide functional genomics using RNA
interference
T. brucei possesses the machinery for RNA interference.
Initially the technique was used to knockdown individual
genes through creation of double stranded RNA and
several efforts have been taken to assess whole classes
of genes e.g. the kinome [32]. It has become possible to
systematically knockdown expression of all genes using
genome-wide libraries of fragments expressed as dsRNACurrent Opinion in Microbiology 2014, 20:162–169
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Regulation of polyamine biosynthesis through a putative decarboxylated S-adenosylmethionine riboswitch. (a) Adjacent genes encode S-
adenosylmethionine decarboxylase (SAMDC) and an enzymatically dead paralogue, termed prozyme. Note the trans-splicing and polyadenylation that
process individual trypanosome mRNAs from large polycistronic precursors. (b) Enzyme activity is high when prozyme binds to SAMDC. Prozyme
translation from its mRNA, however, seems to depend upon the cellular abundance of dcSAM (depicted as red circles here). If abundant, the
metabolite binds to a region of the 30UTR of the transcript and blocks translation. This reduces the level of prozyme, thus reducing activity of SAMDC
and ultimately reducing the levels of dcSAM. As the metabolite levels fall, the 30UTR region of prozyme transcript loses bound metabolite. This allows
translation to start again, providing a typical metabolic feedback loop.in Sca1 meganuclease expressing T. brucei lines (which
have greatly improved transfection efficiency). Initially
by transfecting parasites with the library which was
sequenced before and after propagation in trypanosomes,
hundreds of genes whose loss affected growth rates across
their life cycle were detected [33]. The technique was
then adapted for positive selection for any genes whose
loss of function rendered parasites less susceptible to
trypanocidal drugs [34]. Most recently genes whoseCurrent Opinion in Microbiology 2014, 20:162–169 loss of function prevent parasites differentiating in
response to non-metabolisable cAMP analogues into
growth-arrested stumpy forms have been determined
too [9].
Proteomics
Proteins provide both the structural cornerstone defining
cellular form and also the catalytic capability defining
function. Proteomics allows quantification of individualwww.sciencedirect.com
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teomes of different trypanosome life cycle stages have
been assessed [35]. Methods also exist to locate proteins
in different organelles, and several studies have aimed to
catalogue the glycosomal sub-proteome [36,37], which
has multiple pathways beyond glycolysis including the
pentose phosphate pathway, nucleotide salvage, pyrimi-
dine biosynthesis, arginine kinase, a succinate shunt and
several aspects of lipid metabolism among others. Assem-
bly of proteins into complexes with different partners is
also crucial to cellular function — and delineation of the
trypanosome’s protein complexes is underway. A multi-
enzyme complex specific to the trypanosome system is
the mitochondrial editosome, the complex machinery
driving RNA editing [10].
Mass spectrometry is also able to identify post-transla-
tional modifications to proteins and the phosphopro-
teomes of bloodstream form and procyclic forms were
compared [38,39]. More finely tuned alterations in real
time signalling cascades might also be possible.
Metabolomics
Mass spectrometry (MS), or nuclear magnetic resonance
(NMR), based methods now allow quantification of the
small molecule component of cells and systems. Metabolo-
mics has recently been applied to T. brucei [40]. For example,
experiments where drugs were applied to trypanosomes
have lead to identification of their targets. Eflornithine
provoked a dramatic increase in the abundance of cellular
ornithine and corresponding decrease in putrescine, the
substrate and product, respectively, of the drug’s target,
ornithine decarboxylase [41]. Metabolomics also revealed
that trypanosomes use few nutrients present in rich media
used in their cultivation [42]. Heavy atom labeled substrates
allow the tracing of molecules throughout the metabolic
network and increasingly studies of this type are being
applied to different systems including trypanosomes and
other parasites. These types of analysis will revolutionise
our understanding of the small molecule composition of
living systems and greatly facilitate our ability to follow the
transformations that underlie the building of organisms. For
example, the apicomplexan parasites Toxoplasma gondii [43]
and Plasmodium falciparum [44] were shown to produce
g-aminobutyric acid (GABA) from glutamine by following
the fate of the 13C-heavy atom labeled carbon from
U-13C-glutamine. It was subsequently possible to
demonstrate genes encoding enzymes of GABA shunt
in these parasites. In T. brucei using glucose of which half
was the U-13C-glucose derivative showed how this sub-
strate partitioned into many parts of metabolism including a
glycosomal succinate shunt (since succinate, fumarate and
malate could all be identified [45] with three of their four
carbons labeled, whilst TCA cycle derived versions of these
metabolites would be expected to have either two or four
labeled carbons being derived from acetate). Unusual
metabolites such as octuolse 8-phosphate derived fromwww.sciencedirect.com the pentose phosphate pathway were also identified. Recent
data indicates that bloodstream forms too might have a more
extensive glucose metabolism than previously considered.
In addition to labeling in the steady state, tracer exper-
iments can also be used to determine fluxes through the
system and, increasingly, these approaches will be used to
learn about the pathways involved in creating the trypa-
nosomal system. Metabolomics has also been used to
determine how trypanosomes affect the host plasma
and urine metabolomes [46].
Mathematical modelling of the trypanosomal
system
Computational models of various aspects of the trypano-
somal system have been developed. Ambitious efforts to
model growth of parasites in the mammalian bloodstream
have been employed [47,48] where parasite intrinsic fac-
tors (antigenic variation and quorum sensing growth arrest)
work along with host factors including immune response to
create the characteristic undulating parasitaemia.
Metabolism has also been modelled. Coarse-grained sta-
tic models of metabolism have been generated based on
pathways inferred from genome-wide analysis of enzymes
predicted to be present e.g. KEGG and a community-
based Metacyc related project, termed trypanocyc (http://
metdev.toulouse.inra.fr/). This information will even-
tually be incorporated into a constraint-based model
allowing predictions of metabolic flux through the net-
works as previously attempted for Leishmania [49] and
Trypanosoma cruzi [50].
Dynamic models of key parts of trypanosome metabolism
have also been developed. The first seven enzymes of
glycolysis are localized to the glycosome. Kinetic
parameters for all of the enzymes from glucose transport,
through hexokinase, to pyruvate kinase and the pyruvate
transporter are available. A series of ordinary differential
equations incorporating these kinetic parameters was
created [51] and flux of glucose to pyruvate successfully
simulated. The model has been updated repeatedly as
new information comes to light and made fascinating
predictions on novel ways to kill trypanosomes by pro-
voking differentiation at an inappropriate time [52]. An
interesting effort to include the production and stability
of mRNA and protein turnover for phosphoglycerate
kinase attempted to introduce multi-layered modelling
into the flow of information [53]. Most recently, algo-
rithms permitting inclusion of uncertainty about the
system, including ranges of kinetic parameters reflecting
different parameters measured in different labs, rather
than single representative values, have been introduced
[54]. The topology that describes the distribution of
metabolites between compartments is also uncertain,
given the technical difficulties in precise quantification
within different compartments, and by including thisCurrent Opinion in Microbiology 2014, 20:162–169
166 Host–microbe interactions: parasites
Figure 2
Glucose
Glc-6-P
Fru-6-P
Fru-1,6-BP
DHAP
Gly-3P 1,3-BPGA
3-PGA
2-PGA
PEP
Pyruvate
Glycosome
Cytosol
Glucose
NADH
NAD+
Glycerol
3-PGA
Pyruvate
M
ito
ch
o
n
dr
io
n
DHAP
Gly-3P
H2O
O2
Glucose
ATP
Glc-6-P
6-PGL
NADPHNADP+
6-PG
NADP+
NADPH
Rul-5-P
Rib-5-P
Ribose
ADP
ATP
6-PGL
NADPHNADP+
6-PG
Rul-5-P
Rib-5-P
NADPH NADP+
TS2
Red Ox
ATP
ADP
ADP
ATP
ADP
ATP
CysteineCysteineyGluCys
Glutathione
CO2
ATP
ADP
Methionine
Methionine
SAM
dcSAM
CO2
Ornithine
Ornithine
Putrescine MTA
Spermidine
GlutamineGlutamine
Glutamate
GlycineGlycine
GSp
T(SH)2
ATP
Pi
PPi
ATP   ADP
ADP
ATP
NADP+
NADPH CO2
CO2
ADP
ATP
ADP ATP
?
GA-3-P
ADP
Current Opinion in Microbiology
Glucose and thiol metabolism modelled in Trypanosoma brucei. Mathematical models have been produced that depict the catabolism of glucose via
the glycolytic pathway in the glycosome and also the pentose phosphate pathway which is dually localized to the glycosome and the cytosol. The
polyamine and glutathione/trypanothione pathways have also been modelled mathematically and can be linked to glycolysis and the PPP via NADPH,
a key reductant generated by the PPP and consumed via trypanothione reductase to maintain this pivotal thiol in its reduced form such that it can
operate to maintain cellular redox balance.uncertainty [55] (allowing a fraction of each enzyme to be
active in both cytosol and glycosome) allowed glycolysis
to run even with the presence of recently described
metabolite-permeability pores in the glycosomal mem-
brane [56] (Figure 2).Current Opinion in Microbiology 2014, 20:162–169 The presence of enzymes of a second key pathway of
glucose catabolism, the pentose phosphate pathway
(PPP), in both the glycosome and the cytosol, added
more complexity but a model capable of predicting flux
through both branches was generated. The diversion ofwww.sciencedirect.com
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breaks the proposed bound-phosphate pool in the glyco-
some [57]. Additional reactions must protect against this.
RNAi of ribokinase ruled out this enzyme taking such a
role alone, but a network of other reactions preserving
bound phosphate could be operative.
Other basic kinetic models, this time of the polyamine
and trypanothione pathways, have also been attempted
for T. brucei [58] and T. cruzi [59]. In principle, such
models could be refined and combined with the existing
glycolysis-pentose phosphate pathway model via the
cofactor NADPH which is created by the pentose phos-
phate pathway and is critical to the functioning of the
trypanothione system.
Conclusions
Progress is being made in understanding the trypanoso-
mal cell from the systems perspective, which combines
information from all levels into an operative unit. The
challenges towards this are large. However, as creation of
the system becomes increasingly tangible we can also
look ahead to the host–parasite combined system and in
the same way begin to learn how the host attempts to
control the parasite and how the parasite deals with host
molecular mechanisms to eliminate it.
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